Sanchez E, Krantz E, Kassamali Escobar Z, Tverdek F, Rosen E, Ueda Oshima M
Open Forum Infect Dis. 2024; 11(10):ofae570.
PMID: 39450393
PMC: 11500450.
DOI: 10.1093/ofid/ofae570.
Prayag P, Patwardhan S, Ajapuje P, Melinkeri S, Gadhikar H, Palnitkar S
Indian J Crit Care Med. 2024; 28(2):106-110.
PMID: 38323255
PMC: 10839937.
DOI: 10.5005/jp-journals-10071-24607.
Yanamandra U, Khadwal A, Gupta S, Thomas T, Lad D, Taneja N
Med J Armed Forces India. 2023; 79(6):679-683.
PMID: 37981921
PMC: 10654365.
DOI: 10.1016/j.mjafi.2023.09.001.
Van Galen J, Maldonado S, Grose K, Bagley F, Olivier R, Van Hoose J
Antimicrob Steward Healthc Epidemiol. 2023; 3(1):e158.
PMID: 37771742
PMC: 10523541.
DOI: 10.1017/ash.2023.424.
Metafuni E, Di Marino L, Giammarco S, Bellesi S, Limongiello M, Sora F
Microorganisms. 2023; 11(9).
PMID: 37764025
PMC: 10536954.
DOI: 10.3390/microorganisms11092182.
A case-control study of Clostridioides difficile symptomatic infections in a pediatric cancer hospital.
da Silva A, Barbosa L, Marques L, Carreira L, Fonseca F, Lima A
Rev Paul Pediatr. 2023; 41:e2022117.
PMID: 36921180
PMC: 10013996.
DOI: 10.1590/1984-0462/2023/41/2022117.
Clinical Impact of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Associated Infection Among Patients with Lung Cancer.
Chung Y, Lin Y, Hung M, Ho M, Fang Y
Onco Targets Ther. 2023; 15:1563-1571.
PMID: 36597497
PMC: 9805707.
DOI: 10.2147/OTT.S386807.
Gut Microbiome Modulation and Faecal Microbiota Transplantation Following Allogenic Hematopoietic Stem Cell Transplantation.
Kazmierczak-Siedlecka K, Skonieczna-Zydecka K, Bilinski J, Roviello G, Iannone L, Atzeni A
Cancers (Basel). 2021; 13(18).
PMID: 34572894
PMC: 8464896.
DOI: 10.3390/cancers13184665.
Infection Leading to Intestinal Pneumatosis in a Patient with a Recent Diagnosis of Pancreatic Cancer Local Recurrence: A Case Report and Literature Review.
Uchiyama A, Lopes M, Vana M, Peixoto R
Case Rep Oncol. 2021; 14(2):1111-1117.
PMID: 34413741
PMC: 8339445.
DOI: 10.1159/000513003.
Humoral Immune Response to Toxins A and B in Hospitalized Immunocompromised Patients With Infection.
Alonso C, Papamichael K, Sprague R, Barrett C, Gonzales-Luna A, Daugherty K
Open Forum Infect Dis. 2021; 8(7):ofab286.
PMID: 34258317
PMC: 8271131.
DOI: 10.1093/ofid/ofab286.
A Single-Center Experience and Literature Review of Management Strategies for Infection in Hematopoietic Stem Cell Transplant Patients.
Majeed A, Larriva M, Iftikhar A, Mushtaq A, Campbell P, Nadeem Malik M
Infect Dis Clin Pract (Baltim Md). 2021; 28(1):10-15.
PMID: 33424210
PMC: 7792527.
DOI: 10.1097/ipc.0000000000000798.
Are Antimotility Agents Safe for Use in Infections? Results From an Observational Study in Malignant Hematology Patients.
Kuon C, Wannier R, Sterken D, Fang M, Wolf J, Prasad P
Mayo Clin Proc Innov Qual Outcomes. 2020; 4(6):792-800.
PMID: 33367215
PMC: 7749233.
DOI: 10.1016/j.mayocpiqo.2020.06.005.
High Prevalence of Genetically Related Strains at a Single Hemato-Oncology Ward Over 10 Years.
Waker E, Ambrozkiewicz F, Kulecka M, Paziewska A, Skubisz K, Cybula P
Front Microbiol. 2020; 11:1618.
PMID: 32793147
PMC: 7384382.
DOI: 10.3389/fmicb.2020.01618.
Prospective assessment of Clostridioides (formerly Clostridium) difficile colonization and acquisition in hematopoietic stem cell transplant patients.
Austin K, Sweet M, Likar E, LaSala P, Murray A, Wen S
Transpl Infect Dis. 2020; 22(6):e13438.
PMID: 32767807
PMC: 8371985.
DOI: 10.1111/tid.13438.
Make Sure You Have a Safety Net: Updates in the Prevention and Management of Infectious Complications in Stem Cell Transplant Recipients.
Santos C, Rhee Y, Czapka M, Kazi A, Proia L
J Clin Med. 2020; 9(3).
PMID: 32245201
PMC: 7141503.
DOI: 10.3390/jcm9030865.
Exploratory Evaluation of Bezlotoxumab on Outcomes Associated With Infection in MODIFY I/II Participants With Cancer.
Cornely O, Mullane K, Birch T, Hazan-Steinberg S, Nathan R, Bouza E
Open Forum Infect Dis. 2020; 7(2):ofaa038.
PMID: 32099847
PMC: 7029680.
DOI: 10.1093/ofid/ofaa038.
Clostridioides difficile Infection in the Stem Cell Transplant and Hematologic Malignancy Population.
Misch E, Safdar N
Infect Dis Clin North Am. 2019; 33(2):447-466.
PMID: 31005136
PMC: 6790983.
DOI: 10.1016/j.idc.2019.02.010.
Incidence Rates and Risk Factors of Infection in Solid Organ and Hematopoietic Stem Cell Transplant Recipients.
Ilett E, Helleberg M, Reekie J, Murray D, Wulff S, Khurana M
Open Forum Infect Dis. 2019; 6(4):ofz086.
PMID: 30949533
PMC: 6441586.
DOI: 10.1093/ofid/ofz086.
Intensity of Therapy for Malignancy and Risk for Recurrent and Complicated Clostridium difficile Infection in Children.
Willis Z, Nicholson M, Esbenshade A, Xu M, Slaughter J, Friedman D
J Pediatr Hematol Oncol. 2019; 41(6):442-447.
PMID: 30664104
PMC: 6635100.
DOI: 10.1097/MPH.0000000000001411.
Relationship between clostridium difficile infection and gastrointestinal graft versus host disease in recipients of allogeneic stem cell transplantation.
Bhutani D, Jaiyeoba C, Kim S, Naylor P, Uberti J, Ratanatharathorn V
Bone Marrow Transplant. 2018; 54(1):164-167.
PMID: 30038352
PMC: 6844071.
DOI: 10.1038/s41409-018-0270-x.